Sunitinib malate-Shandong Huashang Chemical Co., Ltd.

Product

Current Position： Home > Product >Pharmaceutical Chemicals >Sunitinib malate

Sunitinib malate

Brand：HS

Model：25kg/drum

Purity：99%

Cas：341031-54-7

Createtime： 2026-04-14
Updatetime： 2026-04-15

Send Message

Product Details

useage	Industrial use
deliveryInfo
appearance	powder
Molecular Weight	532.56
aliasen
supplyCapacity	50000MT/Month
harbor	Qingdao,China
minorder	1KG
Appearance	Yellow to orange or pale yellow crystalline powder

Shandong Huashang Chemical Co., Ltd. is a high-tech enterprise specializing in the research and development, manufacturing, and sales of fine chemicals. Headquartered in Jinan, Shandong, China, we are committed to delivering high-quality products to our global partners. Currently, over 90% of our products are exported to developed markets, including North America, Europe, Japan, South Korea, and the Middle East.

CAS：341031-54-7

Molecular Formula：C26H33FN4O7

Molecular Weight：532.56

Alias：Sunitinib malate salt; SU 11248 malate; Sutent®

Category：Multi-target tyrosine kinase inhibitor, antineoplastic API, pharmaceutical raw material

Physical Properties

Appearance：Yellow to orange crystalline powder or pale yellow crystalline powder (varies with preparation method and purity)

Solubility：Easily soluble in DMSO; slightly soluble in ethanol; difficult to dissolve in water; soluble in aqueous media (pH 1.2-6.8) over 25 mg/mL

Melting Point：189-191℃

Boiling Point：156℃ (lit.)

Stability：Stable under sealed and low-temperature conditions; avoid strong light, high temperature and oxidants; pKa is 8.95

Storage：Sealed, cool (4℃ recommended), dry and dark environment; keep away from oxidants and ignition sources; avoid moisture

Specification Sheet

Item	Standard	Unit	Test Method
Appearance	Yellow to orange or pale yellow crystalline powder	-	Visual inspection
CAS No	341031-54-7	-	Standard confirmation
Molecular Formula	C26H33FN4O7	-	Structural identification
Molecular Weight	532.56	g/mol	Calculation
Purity	≥98.0	%	HPLC
Water Content	≤0.3	%	Karl Fischer (KF)
Melting Point	189-191	℃	Capillary method

Main Application

As a multi-target receptor tyrosine kinase (RTK) inhibitor, it is mainly used as a pharmaceutical API for the treatment of malignant tumors, including gastrointestinal stromal tumor (GIST) after failure of imatinib mesylate treatment due to resistance or intolerance, advanced and/or metastatic renal cell carcinoma (RCC), and unresectable or metastatic well-differentiated pancreatic neuroendocrine tumors (pNET) with disease progression; it inhibits the activity of VEGFR2, PDGFRβ, KIT and other kinases, thereby blocking tumor growth, dissemination and invasion; also used in pharmaceutical research and development, preclinical tumor model experiments and related medical research fields.